432 related articles for article (PubMed ID: 25523883)
41. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
[TBL] [Abstract][Full Text] [Related]
42. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
[TBL] [Abstract][Full Text] [Related]
43. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.
Asadi S; Gholami MS; Siassi F; Qorbani M; Sotoudeh G
Phytother Res; 2020 Apr; 34(4):896-903. PubMed ID: 31788880
[TBL] [Abstract][Full Text] [Related]
44. A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.
Pangallo B; Dellva MA; D'Souza DN; Essink B; Russell J; Goldberger C
J Psychiatr Res; 2011 Jun; 45(6):748-55. PubMed ID: 21511276
[TBL] [Abstract][Full Text] [Related]
45. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
46. A history of early life parental loss or separation is associated with successful cognitive-behavioral therapy in major depressive disorder.
Niciu MJ; Abdallah CG; Fenton LR; Fasula MK; Black A; Anderson GM; Sanacora G
J Affect Disord; 2015 Nov; 187():241-4. PubMed ID: 26363143
[TBL] [Abstract][Full Text] [Related]
47. Curcumin as a putative antidepressant.
Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
[TBL] [Abstract][Full Text] [Related]
48. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.
Al-Karawi D; Al Mamoori DA; Tayyar Y
Phytother Res; 2016 Feb; 30(2):175-83. PubMed ID: 26610378
[TBL] [Abstract][Full Text] [Related]
49. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.
Kemp DE; Ismail-Beigi F; Ganocy SJ; Conroy C; Gao K; Obral S; Fein E; Findling RL; Calabrese JR
J Affect Disord; 2012 Feb; 136(3):1164-73. PubMed ID: 21782251
[TBL] [Abstract][Full Text] [Related]
50. Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression.
Murck H; Braunisch MC; Konrad C; Jezova D; Kircher T
Int Clin Psychopharmacol; 2019 Jan; 34(1):18-26. PubMed ID: 30300165
[TBL] [Abstract][Full Text] [Related]
51. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
[TBL] [Abstract][Full Text] [Related]
52. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.
Panahi Y; Badeli R; Karami GR; Sahebkar A
Phytother Res; 2015 Jan; 29(1):17-21. PubMed ID: 25091591
[TBL] [Abstract][Full Text] [Related]
53. Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.
Shao N; Jia H; Li Y; Li J
Immunol Res; 2017 Aug; 65(4):969-974. PubMed ID: 28349250
[TBL] [Abstract][Full Text] [Related]
54. Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytes.
Murck H; Ploch M; Montgomery S
Int Clin Psychopharmacol; 2018 Jul; 33(4):224-228. PubMed ID: 29489494
[TBL] [Abstract][Full Text] [Related]
55. The effects of crocin on the symptoms of depression in subjects with metabolic syndrome.
Jam IN; Sahebkar AH; Eslami S; Mokhber N; Nosrati M; Khademi M; Foroutan-Tanha M; Ghayour-Mobarhan M; Hadizadeh F; Ferns G; Abbasi M
Adv Clin Exp Med; 2017 Sep; 26(6):925-930. PubMed ID: 29068592
[TBL] [Abstract][Full Text] [Related]
56. Potential Role of Curcumin for the Treatment of Major Depressive Disorder.
Lopresti AL
CNS Drugs; 2022 Feb; 36(2):123-141. PubMed ID: 35129813
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
Lin E; Tsai SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
[TBL] [Abstract][Full Text] [Related]
58. Potentials of curcumin as an antidepressant.
Kulkarni S; Dhir A; Akula KK
ScientificWorldJournal; 2009 Nov; 9():1233-41. PubMed ID: 19882093
[TBL] [Abstract][Full Text] [Related]
59. Curcumin as an add-on to antidepressive treatment.
Pae CU
Clin Neuropharmacol; 2013; 36(6):242-3. PubMed ID: 24201236
[No Abstract] [Full Text] [Related]
60. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression.
Mansur RB; Delgado-Peraza F; Subramaniapillai M; Lee Y; Iacobucci M; Rodrigues N; Rosenblat JD; Brietzke E; Cosgrove VE; Kramer NE; Suppes T; Raison CL; Chawla S; Nogueras-Ortiz C; McIntyre RS; Kapogiannis D
Cells; 2020 Apr; 9(4):. PubMed ID: 32268604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
